Equity Research Database

Institutional Investment Pitches

Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.

Home Letters Funds Account

Mott Capital Management's investment thesis on Grail Inc. ($GRAL) — Q1 2026 | Buyside Digest

All Pitches

View Letter Analysis

$GRALNASDAQGrail Inc.

BULL

Mott Capital Management—GRAL

Fund Letter

Q1 2026

Published May 11, 2026

View Fund Profile

$64.29USD

-20.0% vs last month

$59.65Pitched

+7.8% since pitch

Market Cap$2.8B

P/E (TTM)N/A

52-Wk RangeN/A

Div. YieldN/A

Technical Chart

From the Fund Letter

Grail's stock declined after its cancer screening test failed to meet its early-stage endpoints, though it succeeded in detecting stage 3 cases. The manager believes...

— Michael Kramer

BSD Research Exclusive

Unlock Full Institutional Investment Theses

Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.

6,000+ Institutional Pitches

Proprietary AI Analysis

100 Letter Unlocks/Cycle

SUBSCRIBE TO BSD RESEARCH ($55/MO)Compare All Plans

Already a Research or Pro subscriber? Sign In

◆ Keep Reading

What other investors think about $GRAL, and what else Mott Capital Management is buying.

Other pitches on $GRAL

Other investors who've written on Grail Inc.

No other institutional pitches found for this ticker yet.

View all $GRAL pitches →